A response surface model for synergism between the PPARalpha agonist, gemfibrozil, and the PXR agonist, CDD 3540, in modifying serum HDL cholesterol and ApoA1

cited authors

  • Bachmann, K A; White, D B; Batayneh, Z; Greco, W R

publisher

presented at event